← Back to Search

Pectointercostal fascia blocks for Postoperative Pain (SPIFFY Trial)

Phase 4

Waitlist Available

Led By Wing Lam

Research Sponsored by University of Alberta

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

patients scheduled for cardiac bypass grafting and/or single valve surgery requiring cardiopulmonary bypass.

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up every 6 hours for 24 hours post-operatively

Awards & highlights

SPIFFY Trial Summary

This trial is looking to see if a regional block helps with pain relief for those who have undergone heart surgery.

Eligible Conditions

Postoperative Pain

SPIFFY Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

You are scheduled to have heart surgery that involves the use of a machine to temporarily take over the function of your heart and lungs.

SPIFFY Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ every 6 hours for 24 hours post-operatively

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~every 6 hours for 24 hours post-operatively

This trial's timeline: 3 weeks for screening, Varies for treatment, and every 6 hours for 24 hours post-operatively for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Opioid consumption

Secondary outcome measures

ICU length of stay

Local anesthetic systemic toxicity effects

Opioid consumption in 24 hours

+3 more

SPIFFY Trial Design

2Treatment groups

Experimental Treatment

Placebo Group

Group I: InterventionExperimental Treatment1 Intervention

This group of patients will undergo placement of US guided pectointercostal fascia blocks.

Group II: PlaceboPlacebo Group1 Intervention

The control group patients will receive the same intraoperative analgesia management. A PIF block will not be performed, instead, a peripheral nerve block catheter will be secured to the skin surface and connected to a CADD™ pump. As the catheter is taped to the skin surface the control group patients will not be exposed to the risks of peripheral nerve block placement.

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

University of AlbertaLead Sponsor

886 Previous Clinical Trials

384,777 Total Patients Enrolled

Wing LamPrincipal InvestigatorUniversity of Alberta

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are new patients able to partake in this research endeavor?

"According to the information on clinicaltrials.gov, participant recruitment for this medical trial has terminated as of August 2nd 2022. The study was originally posted October 1st 2022 and is no longer searching for patients at present; however, there are 484 other trials actively recruiting participants."

Answered by AI